ImmunoScape and MiNK Therapeutics Collaborate to Accelerate Novel TCR Identification and Therapeutic Development
MiNK Therapeutics combines its unique, proprietary library of T-cell antigens with ImmunoScape’s cutting-edge platform for rapid discovery of novel T-cell receptors
NUBURU Expands Automotive Manufacturing Offering with Wire Welding Solutions, Enabling High Yield Needed for Mass Production
Secures Purchase Order for BlueScan Solution from a Worldwide Leader in Coils and Motors Production, Replacing Traditional Arc Welding with Next-Gen Blue Laser Wire Welding
ImmunoScape Appoints Systems Immunology and Computational Biology Expert Dr. John Tsang to its Scientific Advisory Board
Expertise from award-winning computational biologist, human immunologist and engineer with experience from Yale, NIH, and NIAID will help advance ImmunoScape’s machine learning capabilities
Zeteo Tech Awarded $1.87M DHS Science & Technology Directorate Contract to Develop and Test the Next Generation of the digitalMALDI® Real-Time Biological Threat Detection Technology
Zeteo Tech, Inc. announced today that it has been awarded a Phase III Small Business Innovation Research contract for $1.87M with a potential value of up to $5.86 million (including options) from the U.S. Department of Homeland Security (DHS).
CytoTronics’ Breakthrough Semiconductor Platform Poised to Set New Standard in High-Throughput Phenotypic Screening for Drug Discovery
Published data showcases the company’s potential to revolutionize pharmaceutical research
South 8 Debuts its Arctic™ LiGas® Battery Electrolyte for Reliable, Safe Performance in Extreme Environments
South 8’s new 18650 battery cell uses the company’s liquefied gas electrolyte to minimize fire risk while delivering world-record cold weather performance
TeraPore Launches IsoBlock® VF Viral Filtration Product Line with Proprietary Membrane Technology that Delivers Consistent Results
TeraPore Technologies has commercially launched the flagship IsoBlock® VF product line for parvovirus removal from biopharmaceuticals.
EnCharge AI Closes Additional $22.6M from VentureTech Alliance, RTX Ventures and ACVC Partners to Unlock AI Compute
TeraPore Technologies has commercially launched the flagship IsoBlock® VF product line for parvovirus removal from biopharmaceuticals.
Xendee Unveils PROPOSE: A Revolutionary Sales and Business Development Tool for EV Fast-Charging Infrastructure and Distributed Energy Systems
With additional backing from top-tier strategic and financial investors, the company’s dry electrode battery manufacturing technology reduces CO2 emissions, speeds the battery manufacturing process, and reduces cost for an expanding global EV market
South 8 Technologies Welcomes Industry Veteran Tom Stepien to CEO Role
South 8 Technologies has appointed industry veteran Tom Stepien as Chief Executive Officer. He also joins the South 8 Board of Directors.